Flood of IPOs has slowed to a trickle in 2022
After reaching new heights in 2021, including a $150 million capital raise that closed in July and surpassing $100 million in annual recurring revenue, Santa Barbara-based Impact Technologies was preparing to go public in 2022. But, with rising inflation and interest rates decimating the stock market, the IPO money that was available in 2021 has Read More →
Semtech reports earnings and revenue growth in Q1
Camarillo-based Semtech Corp. reported record sales and rising earnings when it announced its financial results for the first quarter of 2022 on June 1. Semtech, a semiconductor company specializing in Internet of Things applications, saw net income increase in the first quarter of 2022, as the company netted $38 million, or 59 cents per share, Read More →
Our View: The politics of oil and water are both changing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Camarillo biotech company pursuing cancer treatments raises $20M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Gender pay gap has faded away among region’s younger workers
Historically, women in America have earned lower average wages than men. But according to a recent study by the Pew Research Center, the wage gap among people under 30 has significantly narrowed in some areas, including the entire tri-county region. Recent Pew analysis of the 2019 American Community Survey, an annual Census Bureau program and Read More →
Real Estate: Moorpark shopping center refinanced with $24M loan
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind takes next step in rebuild with new FDA approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
